Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-005-8 | CAS number: 102-09-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
ORAL
The NOAEL for fertility in rats was determined to be 15 000 ppm in the diet, equating to about 1561 mg/kg bw/day for males and 2432 mg/kg bw/day for females, OECD 416 (and aspects of OECD 415 and OECD 407), Eiben (2003a)
Link to relevant study records
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Principles of method if other than guideline:
- One-generation study following OECD TG 416 (2001) without treatment of F1 weanlings after developmental milestones had occurred (balano-preputial separation or vaginal opening at an age of about 8 weeks). The conduct of this study includes also recommendations of OECD TG 415 (adopted 1983) and 407 (only open field observations and Functional Observation Battery)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- -number of animals F0: 25/sex/group
- number of viable pups F1: 196-244/group
- Age: about 6 w
- Weight at study initiation: males: 111-151 g; females: 96-132 g - Route of administration:
- oral: feed
- Details on exposure:
- oral feeding in a diet containing 1 % peanut oil
diets were prepared twice weekly - Details on mating procedure:
- - M/F ratio per cage: 1/1
- Length of cohabitation: up to 21 days
- Proof of pregnancy: sperm in vaginal smear - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The determination of diphenyl carbonate in the feed samples was done after extraction by gas chromatography. Content, homogeneity and stability of diphenyl carbonate in food was confirmed under GLP.
- Duration of treatment / exposure:
- Exposure period: about 18 weeks (see test conditions)
Premating exposure period (males): 11 weeks
Premating exposure period (females): 11 weeks - Frequency of treatment:
- continuous
- Details on study schedule:
- Animals were exposed during the premating period of about 11 weeks, and during the mating period of up to 3 weeks. Males were sacrificed after the mating period. Females were further exposed during pregnancy and lactation, and were sacrificed when F1 offspring was weaned (after 4 weeks). At the same time most F1 animals were sacrificed, except of one F1 male and one F1 female per litter, which were sacrificed after a further treatment period of about 4 weeks, when developmental milestones had occurred (balano-preputial separation or vaginal opening).
- Dose / conc.:
- 1 500 ppm
- Remarks:
- (nominal in diet)
- Dose / conc.:
- 5 000 ppm
- Remarks:
- (nominal in diet)
- Dose / conc.:
- 15 000 ppm
- Remarks:
- (nominal in diet)
- No. of animals per sex per dose:
- 25
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- Rationale for dose selection:
based on a subchronic feeding pilot study (Eiben, 2002. Diphenylcarbonate (DPC) Subchronic study in Wistar rats (Pilot study for a one-generation study with administration in the diet). Report No. AT00045. Oct 22, 2002) See also chapter 7.5.1 (repeated dose toxicity: oral).
ACTUAL DOSE (mean) RECEIVED BY DOSE LEVEL BY SEX:
- low dose: 132 (m) or 219 (f) mg/kg bw/day
- mid dose: 427 (m) or 710 (f) mg/kg bw/day
- high dose: 1561 (m) or 2432 (f) mg/kg bw/day - Positive control:
- none
- Parental animals: Observations and examinations:
- CLINICAL OBSERVATIONS AND FREQUENCY:
- Clinical signs: at least weekly
- Mortality: twice daily
- Body weight: weekly
- Food consumption: weekly
- Water consumption: no data
- Ophthalmoscopic examination: no data
- Haematology: no data
- Biochemistry: no data
- Urinalysis: no data
- functional observation battery : yes - Oestrous cyclicity (parental animals):
- yes
- Sperm parameters (parental animals):
- yes (control and 15000 ppm group) spermatozoa motility and viability, spermatozoa morphology, quantitative determination of spermatozoa in epididymis, quantitative determination of homogenization resistant spermatid heads in the testis
- Litter observations:
- - determination of offspring toxicity according to OECD TG 416
- Postmortem examinations (parental animals):
- - gross pathology F0: organs as given in OECD TG 416
- organ weights F0: as given in OECD TG 416
- Histopathology F0 (control and 15000 ppm group): adrenals, liver, kidney spleen, pituitary, vagina, uterus/cervix, ovaries, oviducts, seminal vesicles with coagulation glands, prostate, brain, mammary glands with skin, testes, epididymides, thyroids/parathyroids - Postmortem examinations (offspring):
- - gross pathology F1: organs as given in OECD TG 416
- organ weights F1: brain, spleen, thymus, testes, epididymides, uterus were determined for the first male and female living F1 weanling of each litter
- Histopathology F1 weanlings: ovaries - Statistics:
- Dunnet-Test with variance analysis for body and organ weights; Kruskal-Wallis-Test with a Steel-Test for food consumption data
- Reproductive indices:
- - Reproduction parameters: estrus cycle staging, insemination rate, duration of pregnancy, data on pups
- Offspring viability indices:
- - determination of offspring toxicity according to OECD TG 416
- developmental milestones and investigations in post weaned F1 rats: age and body weight at which balano-preputial separation and vaginal opening occurred
- Functional Observation Battery: yes - Clinical signs:
- no effects observed
- Description (incidence and severity):
- No treatment-related effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Slightly reduced mean body weights (up to 8%) became obvious in high dosed animals
- Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- No treatment-related effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- no effects observed
- Description (incidence and severity):
- no indication of neurotoxic potential
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- no indication of neurotoxic potential
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- OVARIES: Number of corpora lutea slightly elevated in all dose groups; large corpora lutea exhibited an infiltration of predominantly mononuclear cells and contained granulated luteal cells. Number of hypertrophic ovarian interstitial cells increased with severity score increasing in a dose dependent manner.
LIVER: Hepatocellular hypertrophy was found in low frequency and severity score predominantly in males. ADRENAL GLANDS: In mid and high dosed males the frequency of mixed-size vacuolation of Zona fasciculata and partly also glomerulosa cells was slightly and the severity moderately increased. In females microvesicular vacuolation and hypertrophy of Zona fasciculata cells were found in high incidences in all dose groups. The severity score increased dose-dependently. - Histopathological findings: neoplastic:
- no effects observed
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- No treatment-related effects
- Reproductive function: sperm measures:
- no effects observed
- Description (incidence and severity):
- No significant findings were noted
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No treatment-related effects
- Dose descriptor:
- NOAEL
- Remarks:
- parental toxicity
- Effect level:
- 1 500 ppm
- Sex:
- male
- Basis for effect level:
- other: about 132 mg/kg bw/day
- Dose descriptor:
- LOAEL
- Remarks:
- parental toxicity
- Effect level:
- 1 500 ppm
- Sex:
- female
- Basis for effect level:
- other: about 219 mg/kg bw/day based on increased relative and absolute adrenal weights with histopathological changes in the zona fasciculata, and morphological changes in the ovaries
- Dose descriptor:
- NOAEL
- Remarks:
- fertility
- Effect level:
- 15 000 ppm
- Sex:
- male
- Basis for effect level:
- other: about 1561 mg/kg bw/day
- Dose descriptor:
- NOAEL
- Remarks:
- fertility
- Effect level:
- 15 000 ppm
- Sex:
- female
- Basis for effect level:
- other: about 2432 mg/kg bw/day
- Critical effects observed:
- not specified
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No treatment-related effects
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- body weights at weaning: in 15000 ppm pups reduced by 11-12% (this is most likely directly induced by compound consumption rather than a reprotoxic effect)
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- organ weights at weaning: at 15000 ppm reduced absolute spleen weights in both sexes (ca. -20%; relative weights not affected) and reduced absolute (-29%) and relative (-16%) thymus weights in females
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- No treatment related effects
- Histopathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- histopathology F1 at weaning: at 1500 ppm and above in ovaries large corpora lutea exhibited an infiltration of predominantly mononuclear cells (1/5/9/11); many of corpora lutea contained granulated luteal cells (0/2/7/8); hypertrophy of ovarian interstitial cells (0/4/10/23) with severity score increasing in a dose dependent manner
- Description (incidence and severity):
- OFFSPRING TOXICITY F1:
- total number of pups (228, 249, 204, 220)
- mean litter size (10.71, 9.72, 8.73, 9.91)
- sex ratio (% males: 49.31, 53.41, 45.66, 52.67)
- live birth index (98.74%, 97.47%, 93.12%, 99.04%)
- mean pup weight in g (m: 5.71, 5.97, 5.94, 5.79; f: 5.48, 5.57, 5.65, 5.39)
- viability index day 4 (98.68%, 86.67%, 85.51%, 94.17%) - Dose descriptor:
- NOAEL
- Remarks:
- toxicity
- Generation:
- F1
- Effect level:
- 5 000 ppm
- Sex:
- male
- Basis for effect level:
- histopathology: non-neoplastic
- Dose descriptor:
- LOAEL
- Remarks:
- toxicity
- Generation:
- F1
- Effect level:
- 1 500 ppm
- Sex:
- female
- Basis for effect level:
- histopathology: non-neoplastic
- Critical effects observed:
- not specified
- Reproductive effects observed:
- no
- Conclusions:
- Reproduction parameters and fertility were not affected up to the highest administered dose. The NOAEL for fertility can therefore be considered as 15000 ppm or 1551 mg/kg bw for males and 2432 mg/kg bw for females.
- Executive summary:
The reproductive toxicity of diphenyl carbonate was investigated in a one-generation study in rats, following the two-generation study protocol of OECD 416 (2001) without treatment of F1 weanlings after developmental milestones (balano-preputial separation or vaginal opening at an age of about 8 weeks) had occurred. The conduct of this study included also recommendations of OECD 415 (adopted 1983) and OECD 407 (open field observations and Functional Observation Battery).
Durng the study diphenyl carbonate was administered via the diet to 25 male and 25 female Wistar rats per group in doses of 1500, 5000, or 15 000 ppm. The rationale for dose selection was based on a sub chronic feeding pilot study. The calculated actual doses for parental animals were 132, 427, and 1561 mg/kg bw/day for males and 219, 710, and 2432 mg/kg bw/day for females.
The animals were dosed for a period of 11 weeks prior to mating, then for a period of up to three weeks during mating. Males were sacrificed after the mating period, females were further treated during pregnancy and weaning and were sacrificed together with F1 animals when 28 day-old F1 offspring was weaned.
One F1 male and one F1 female per litter were necropsied after a further treatment period of about 4 weeks, when sexual maturity was reached.
Mortality and clinical appearance of F0 and F1 animals were unchanged throughout all dose groups. Slightly reduced mean body weights (up to 8 %) became obvious in the high dose parental animals. F1 animals of the high dose group gained less body weight. This effect became significant at weaning when pups increasingly ingested diphenyl carbonate via their own food and can therefore be regarded as a primary effect.
Organ weight determination and histopathology revealed diphenyl carbonate dependent changes in the liver, adrenals and ovaries of F0 animals. Changes in ovarian morphology was also observed in treated F1 females in a dose dependent manner throughout all doses, showing a similar appearance to that observed in F0 females. Observations on spermatology parameters, performed on control and high dose males with regard to spermatozoa motility, viability and morphology, quantitative determination of spermatozoa in epididymis, and quantitative determination of homogenisation resistant spermatid heads in the testis, were not adversely affected by treatment.
Reproduction parameters such as insemination index, mating performance, fertility index, gestation index, duration of pregnancy, live birth index, birth weights, prenatal loss and percentages of pups born, litter size, viability and lactation index were not affected by diphenyl carbonate. Iin post weaned F1 animals (1 male and 1 female per litter; sacrificed at an age of 8 weeks) sexual maturation was not affected. The histopathological changes observed in F0 and F1 ovaries and F0 adrenals therefore did not influence reproductive performance.
The NOAEL for fertility in rats was determined to be 15 000 ppm diphenyl carbonate in the diet, equating to about 1561 mg/kg bw/day for males and 2432 mg/kg bw/day for females. For F1 males the NOAEL for general toxicity was 5000 ppm, with a LOAEL at 15 000 ppm based on reduced body weight gain. A NOAEL for F1 females could not be determined as changes in the ovaries were seen down to the lowest tested dose (1500 ppm). The NOAEL for general toxicity in parental males was 1500 ppm (about 132 mg/kg bw/day), with the LOAEL at 5000 ppm (about 427 mg/kg bw/day) based on increased relative liver weights with hepatocellular hypertrophy, and histopathological changes in adrenals. For parental females a NOAEL for general toxicity could not be determined in this study because of histopathological changes in adrenals and ovaries in all dose groups.
Reference
- fertility index (91.7%, 100%, 91.7%, 100%)
- gestation index (95.5%, 100%, 100%, 100%)
- duration of gestation (21.9, 22.29, 22.70, 22.33 days)
- developmental milestones in F1 weanlings: no treatment effect on sexual maturation
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 561 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- The study was performed under GLP conditions and in accordance with a standardised guideline. The quality of the database is therefore considered to be good.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Oral
The key study (Eiben, 2003a) was conducted under GLP conditions and in accordance with standardised guidelines. The study has therefore awarded a reliability score of 1 in accordance with the criteria for assessing data quality as set forth by Klimisch et al. (1997).
The reproductive toxicity of diphenyl carbonate was investigated in a one-generation study in rats, following the two-generation study protocol of OECD 416 (2001) without treatment of F1 weanlings after developmental milestones (balano-preputial separation or vaginal opening at an age of about 8 weeks) had occurred. The conduct of this study included also recommendations of OECD 415 (adopted 1983) and OECD 407 (open field observations and Functional Observation Battery).
Diphenyl carbonate was administered via the diet to 25 male and 25 female Wistar rats per group in doses of 1500, 5000, or 15 000 ppm. The rationale for dose selection was based on a sub chronic feeding pilot study. The calculated actual doses for parental animals were 132, 427, and 1561 mg/kg bw/day for males and 219, 710, and 2432 mg/kg bw/day for females.
The animals were dosed for a period of 11 weeks prior to mating, then for a period of up to three weeks during mating. Males were sacrificed after the mating period, females were further treated during pregnancy and weaning and were sacrificed together with F1 animals when 28 day-old F1 offspring was weaned.
One F1 male and one F1 female per litter were necropsied after a further treatment period of about 4 weeks, when sexual maturity was reached.
Mortality and clinical appearance of F0 and F1 animals were unchanged throughout all dose groups. Slightly reduced mean body weights (up to 8 %) became obvious in the high dose parental animals. F1 animals of the high dose group gained less body weight. This effect became significant at weaning when pups increasingly ingested diphenyl carbonate via their own food and can therefore be regarded as a primary effect.
Organ weight determination and histopathology revealed diphenyl carbonate dependent changes in the liver, adrenals and ovaries of F0 animals. Changes in ovarian morphology was also observed in treated F1 females in a dose dependent manner throughout all doses, showing a similar appearance to that observed in F0 females. Observations on spermatology parameters, performed on control and high dose males with regard to spermatozoa motility, viability and morphology, quantitative determination of spermatozoa in epididymis, and quantitative determination of homogenisation resistant spermatid heads in the testis, were not adversely affected by treatment.
Reproduction parameters such as insemination index, mating performance, fertility index, gestation index, duration of pregnancy, live birth index, birth weights, prenatal loss and percentages of pups born, litter size, viability and lactation index were not affected by diphenyl carbonate. Iin post weaned F1 animals (1 male and 1 female per litter; sacrificed at an age of 8 weeks) sexual maturation was not affected. The histopathological changes observed in F0 and F1 ovaries and F0 adrenals therefore did not influence reproductive performance.
The NOAEL for fertility in rats was determined to be 15 000 ppm diphenyl carbonate in the diet, equating to about 1561 mg/kg bw/day for males and 2432 mg/kg bw/day for females. For F1 males the NOAEL for general toxicity was 5000 ppm, with a LOAEL at 15 000 ppm based on reduced body weight gain. A NOAEL for F1 females could not be determined as changes in the ovaries were seen down to the lowest tested dose (1500 ppm). The NOAEL for general toxicity in parental males was 1500 ppm (about 132 mg/kg bw/day), with the LOAEL at 5000 ppm (about 427 mg/kg bw/day) based on increased relative liver weights with hepatocellular hypertrophy, and histopathological changes in adrenals. For parental females a NOAEL for general toxicity could not be determined in this study because of histopathological changes in adrenals and ovaries in all dose groups.
EOGRTS
In accordance with section 1 of REACH Annex XI, it is considered justified to omit the Extended One Generation Reproductive Toxicity Study (EOGRTS) required in section 8.7.3 of Annexes IX and X on the grounds that testing is not scientifically necessary. The data provided to address the repeat dose and reproductive toxicity endpoints do not suggest any adverse effects that would indicate this study to be necessary. The one-generation study provided was conducted with additional parameters and it is considered that the study is broadly equivalent to the EOGRTS and therefore the existing data are adequate to address this endpoint.
The one-generation study for diphenyl carbonate was performed in accordance with the standardised guideline OECD 416 of 2001 (without treatment of F1 weanlings), which covers several additional parameters when compared to the classical one-generation study (OECD 415). These include oestrous cycle staging and sperm parameter analysis in parental animals, but also determination of developmental milestones in F1 weanlings, measured as effects on vaginal opening and balano-preputial separation. Additionally, organ weights and gross pathology findings were recorded for F1 animals and the ovaries of F1 females were histopathologically investigated. Due to the fact that treatment with diphenyl carbonate had no influence on reproductive performance in this study and a NOAEL of greater than 1500 mg/kg bw/day could be established for fertility, it is considered that further invertebrate testing to investigate reproductive effects would not be a responsible use of animals.
Effects on developmental toxicity
Description of key information
ORAL
The NOAEL for maternal toxicity and developmental toxicity in rats was 50 mg/kg bw/day, OECD 414, Klaus (2002)
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- GLP compliance:
- yes
- Limit test:
- no
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- according to Guideline
body weight on day 0 p.c.: 207 to 249 g
age of females on day 0 p.c.: 12-16 weeks - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Details on exposure:
- vehicle: carboxymethylcellulose 0.5 % in deionized water
administration volume: 10 ml/kg bw
The dose levels used were selected according to a preceding dose-range finding study (Study No. T0062796) in rats with dose levels of 0, 20, 125, and 750 mg/kg bw/d. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Investigations on stability and homogeneity of the test compound in samples of 1 mg/ml and 100 mg/ml were performed. Stability and homogeneity were confirmed.
- Details on mating procedure:
- 1 male/2 females per cage; if sperm was detected in the vaginal smear this day was day 0 of gestation
- Duration of treatment / exposure:
- days 6 - 19 of gestation
- Frequency of treatment:
- once daily
- Duration of test:
- cesarian section and sacrifice at day 20 of gestation
- Dose / conc.:
- 50 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 200 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 750 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- No. of females/dose: 25 (50 mg/kg and 750 mg/kg group: 28) inseminated females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Sex: female
Duration of test: sacrifice on day 20 of gestation - Maternal examinations:
- Body weight gain: on day 0 p.c. and daily from day 6-20
Food consumption: yes
Water consumption: yes (by visual estimation)
Clinical observations: appearance, behaviour, excretory products and mortality, from day 0 -20 twice daily
Gross pathological examination: at time of cesarian section on day 20 p.c. or after death/premature sacrifice - Ovaries and uterine content:
- gravid uterine weight, no. of corpora lutea, no. of implantations, no. of resorptions, placenta weight
- Fetal examinations:
- Examination of fetuses: number, weight and sex of live fetuses, external, visceral and skeletal malformations
Total numer of live fetuses examined: 275/249/269/253 - Statistics:
- Kruskal-Wallis test, analysis of variance, Dunnett's test, Chi² test were used
- Historical control data:
- yes
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- only in 750 mg/kg group: signs of severe toxicity after administration (convulsions and ventral posture), which disappeared within 4 hours; in surviving females such clinical signs became less severe or were not longer evident with increasing duration of treatment; piloerection;
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- In 750 mg/kg group 5 females died (4 after 1st dose, 1 after 7th dose)
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Body weight development: stat. sign. reduced at 750 mg/kg throughout the entire study (mean body weight gain day 0-20 reduced by 24%); in the 200 mg/kg bw/day group stat. sign. reduced only on day 6-7 p.c. and remained marginally reduced up to sacrifice
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- distinctly reduced in 750 (up to 36%) and slightly reduced in 200 mg/kg group (up to 12% on days 6-12)
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Description (incidence and severity):
- water consumption increased only in high dosed females
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Description (incidence and severity):
- Placenta weight: unaffected
- Description (incidence and severity):
- In 750 mg/kg group some females showed empty of gas filled stomach, related to morbidity/mortility and regarded as unspecific finding.
Placenta appearance: at 750 mg/kg engorged placentae/ necrotic placental borders - Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- not examined
- Histopathological findings: neoplastic:
- not examined
- Description (incidence and severity):
- Total number of females with implantations (vehicle control, 50, 200, 750 mg/kg bw/d): 23/22/25/21
No. of resorptions: 0/0/1/0
Total number of females with viable fetuses: 23/22/24/21
No. of corpora lutea/female: 14.3/14.3/14.9/14.7
Postimplantation loss/female: no meaningful effects (0.7/0.8/1.1/1.2) since no. of viable fetuses per litter not affected and inbetween historical control range - Dose descriptor:
- NOAEL
- Effect level:
- >= 50 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects: yes
Details on embryotoxic / teratogenic effects:
see Remarks on results
For selected fetuses a peer review of fetal visceral findings was performed by Tesh Consultants International, UK. - Dose descriptor:
- NOAEL
- Effect level:
- >= 50 mg/kg bw/day
- Basis for effect level:
- other: teratogenicity
- Abnormalities:
- not specified
- Developmental effects observed:
- not specified
- Conclusions:
- Under the conditions of this study, the NOAEL for maternal toxicity and developmental toxicity in rats was 50 mg/kg bw/day. At 200 mg/kg bw/day slight maternal toxicity occurred and a retarding effect on foetal skeletal ossification of toes and cervical vertebral bodies could not be completely excluded.
- Executive summary:
The developmental toxicity of the substance was investigated in a study which was conducted in accordance with the standardised guideline OECD 414 under GLP conditions.
During the study test material was administered to rats once daily via oral gavage at dose levels of 50, 200 and 750 mg/kg bw to 25 females per dose. The vehicle was 0.5 % carboxymethylcellulose in deionised water and the dose volume was 10 mL/kg bw. Maternal animals were dosed on days 6 - 19 of gestation and underwent caesarean section and sacrifice on day 20 of gestation.
Administration of 750 mg/kg bw/day led to severe maternal toxicity (mortality, convulsions, piloerection, body weight loss). Foetuses of this dose group showed reduced body weights and increased incidences of unspecific malformations (mainly dysplastic forelimb bones).
No effects were observed on the number of females with implantations, number of resorptions, total number of females with viable foetuses, the number of corpora lutea per female, post implantation loss or placenta weight. At 750 mg/kg bw/day, placentae appeared to be engorged with necrotic placental borders.
The number of dead foetuses did not affect the mean number of viable foetuses per litter and was comparable to the incidences in historical control, so that toxicological relevance was not assumed.
The sex ratio of offspring was not affected by treatment. The foetal weight in the high dose group was statistically significantly reduced.
Foetal malformations were observed at 750 mg/kg bw (severe maternally toxic dose); the incidence of common malformations increased on a foetal and litter basis: dysplastic forelimb bones (foetal incidence 5.5 %, litter incidence 33.3 % compared to 0 % in control, though in historical control groups incidences of up to 4.3/20 % were seen); 2 cases of multiple malformations; 3 cases of atrial septal defect of the heart within 3 litters; 2 cases of flat and stretched kidneys; 1 case of situs inversus; and 1 case of shortened tail with missing sacral and caudal vertebrae.
There were no test material-related effects on foetal external and visceral deviations. The following foetal skeletal deviations (including cartilaginous deviations) were seen: slightly retarded ossification in comparison to control could not be completely excluded in the 200 mg/kg group (retarded ossification of distal phalanges of toes, cervical vertebral bodies, sacral vertebral arches and wavy ribs; this was only statistically significant when calculated on a foetal basis) and was evident to a more pronounced degree in the 750 mg/kg group. Foetal cartilage was not affected. The overall number and type of malformations were not increased at a dose level up to and including 200 mg/kg bw/day.
Under the conditions of this study, the NOAEL for maternal toxicity and developmental toxicity in rats was 50 mg/kg bw/day. At 200 mg/kg bw/day slight maternal toxicity occurred and a retarding effect on foetal skeletal ossification of toes and cervical vertebral bodies could not be completely excluded.
Reference
No. of viable fetuses: 275/249/269/253
No. of dead fetuses: 0/0/2/1 (deaths did not affect the mean number of viable fetuses per litter and was comparable to the incidences in historical control, so that toxicological relevance was not assumed)
Sex ratio (% males): not affected (48.4/50.1/50.5/48.6)
Fetal weight (mean in g): 3.77/3.74/3.64/3.40 (high dose group p<0.01)
Fetal malformations: at 750 mg/kg bw (severe maternally toxic dose) incidence of common malformations increased on a fetal and litter basis as
- dysplastic forelimb bones: fetal incidence 5.5%, litter incidence 33.3% compared to 0% in control (in historical control groups indicences of up to 4.3/20% were seen)
- 2 cases of multiple malformations
- 3 cases of atrial septal defect of the heart within 3 litters
- 2 cases of flat and stretched kidneys
- 1 case of situs inversus
- 1 case of shortened tail with missing sacral and caudal vertebrae
Fetal external and visceral deviations: no TS-related effects
Fetal skeletal deviations including cartilaginous deviations: slightly retarded ossification in comparison to control could not be completely excluded in the 200 mg/kg group (retarded ossification of distal phalanges of toes, cervical vertebral bodies, sacral vertebral arches and wavy ribs: only stat. sign. when calculated on a fetal basis) and was evident to a more pronounced degree in the 750 mg/kg group.
Fetal cartilage was not affected. The overall number and type of malformations were not increased at a dose level up to and including 200 mg/kg bw/day.
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 50 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The key study was conducted in accordance with a standardised guideline under GLP conditions. It was awarded a reliability score of 1 in accordance with the criteria for assessing data quality as set forth by Klimisch et al. (1997). Therefore, the quality of this database is considered to be high.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
The key study (Klaus, 2002) was conducted in accordance with the standardised guideline OECD 414 under GLP conditions. It was awarded a reliability score of 1 in accordance with the criteria for assessing data quality as set forth by Klimisch et al. (1997).
In a developmental toxicity study in Wistar rats, the test material was administered once daily via oral gavage at dose levels of 50, 200 and 750 mg/kg bw to 25 females per dose. The vehicle was 0.5 % carboxymethylcellulose in deionised water and the dose volume was 10 mL/kg bw. Maternal animals were dosed on days 6 - 19 of gestation and underwent caesarean section and sacrifice on day 20 of gestation.
Administration of 750 mg/kg bw/day led to severe maternal toxicity (mortality, convulsions, piloerection, body weight loss). Foetuses of this dose group showed reduced body weights and increased incidences of unspecific malformations (mainly dysplastic forelimb bones).
No effects were observed on the number of females with implantations, number of resorptions, total number of females with viable foetuses, the number of corpora lutea per female, post implantation loss or placenta weight. At 750 mg/kg bw/day, placentae appeared to be engorged with necrotic placental borders.
The number of dead foetuses did not affect the mean number of viable foetuses per litter and was comparable to the incidences in historical control, so that toxicological relevance was not assumed.
The sex ratio of offspring was not affected by treatment. The foetal weight in the high dose group was statistically significantly reduced.
Foetal malformations were observed at 750 mg/kg bw (severe maternally toxic dose); the incidence of common malformations increased on a foetal and litter basis: dysplastic forelimb bones (foetal incidence 5.5 %, litter incidence 33.3 % compared to 0 % in control, though in historical control groups incidences of up to 4.3/20 % were seen); 2 cases of multiple malformations; 3 cases of atrial septal defect of the heart within 3 litters; 2 cases of flat and stretched kidneys; 1 case of situs inversus; and 1 case of shortened tail with missing sacral and caudal vertebrae.
There were no test material-related effects on foetal external and visceral deviations. The following foetal skeletal deviations (including cartilaginous deviations) were seen: slightly retarded ossification in comparison to control could not be completely excluded in the 200 mg/kg group (retarded ossification of distal phalanges of toes, cervical vertebral bodies, sacral vertebral arches and wavy ribs; this was only statistically significant when calculated on a foetal basis) and was evident to a more pronounced degree in the 750 mg/kg group. Foetal cartilage was not affected. The overall number and type of malformations were not increased at a dose level up to and including 200 mg/kg bw/day.
Under the conditions of this study, the NOAEL for maternal toxicity and developmental toxicity in rats was 50 mg/kg bw/day. At 200 mg/kg bw/day slight maternal toxicity occurred and a retarding effect on foetal skeletal ossification of toes and cervical vertebral bodies could not be completely excluded.
Justification for classification or non-classification
In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to toxicity to reproduction and developmental toxicity.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.